Mrđenović, S., Zhang, Y., Wang, R., Yin, L., Chia Yi Chu, G., Yin, L. ... Chung, L. W. K. (2019). Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer, 125. (13), 2222-2232. doi: 10.1002/cncr.32033
Mrđenović, Stefan, et al. "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer, vol. 125, no. 13, 2019, pp. 2222-2232. https://doi.org/10.1002/cncr.32033
Mrđenović, Stefan, Yi Zhang, Ruoxiang Wang, Lijuan Yin, Gina Chia Yi Chu, Liyuan Yin, Michael Lewis, Marija Heffer, Haiyen E. Zhau and Leland W. K. Chung. "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer 125, no. 13 (2019): 2222-2232. https://doi.org/10.1002/cncr.32033
Mrđenović, S., et al. (2019) 'Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate', Cancer, 125(13), pp. 2222-2232. doi: 10.1002/cncr.32033
Mrđenović S, Zhang Y, Wang R, Yin L, Chia Yi Chu G, Yin L, and sur.. Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer [Internet]. 2019 [cited 2024 November 17];125(13):2222-2232. doi: 10.1002/cncr.32033
S. Mrđenović, et al., "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate", Cancer, vol. 125, no. 13, pp. 2222-2232, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:239:300171. [Accessed: 17 November 2024]